StreetAlpha
BrightSpring Health Services, Inc. · SEC Form 4

BTSG Insider Trading

From SEC Form 425 trades in 2 yearsUpdated Nov 19, 2026

Every open market buy and sale of BrightSpring Health Services, Inc. stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are only selling over the last 12 months: $0 bought and $3.4B sold.

← BTSG stock page

Insiders are only selling
Bought, 12 months$00 buys · 0 insiders
Sold, 12 months$3.4B11 sales · 8 insiders
Net−$3.4Bbought minus sold
Planned sales–of sold value, 10b5-1 plans

Buying and selling by month

open market, last 12 months
DecJanFeb2026-03: sold $1.6BMarAprMay2026-06: sold $1.7BJunJulAug2026-09: sold $874KSepOctNov
Bought (up)Sold (down)
AI Pro · insider alerts

Get an alert when BTSG insiders trade

We read every Form 4 the moment the SEC posts it and tell you when an BTSG officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.

Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.

Every BTSG insider trade

2 years · newest first
InsiderTypePriceHeld afterFiled
Sep 14, 2026Scott A. GreenwellPresident, PharMericaSale plan15,099$57.91$874K31,246Sep 16Form 4
Jun 5, 2026Jennifer A PhippsCFOSale35,000$58.75$2.1M250,224Jun 5Form 4
Jun 5, 2026Lisa A NalleySee RemarksSale35,000$58.75$2.1M131,948Jun 5Form 4
Jun 5, 2026Jon B RousseauSee RemarksSale260,000$58.75$15.3M0Jun 5Form 4
Jun 5, 2026KKR Phoenix Aggregator L.P.10% ownerSale14,669,771$58.45$857M27,154,488Jun 5Form 4
Jun 5, 2026KKR Group Partnership L.P.10% ownerSale14,669,771$58.45$857M27,154,488Jun 5Form 4
Mar 4, 2026Jennifer A PhippsCFOSale35,000$41.15$1.4M196,840Mar 6Form 4
Mar 4, 2026Jon B RousseauSee RemarksSale220,000$41.15$9.1M1,023,880Mar 6Form 4
Mar 4, 2026Lisa A NalleySee RemarksSale30,000$41.15$1.2M110,594Mar 6Form 4
Mar 4, 2026KKR Phoenix Aggregator GP LLC10% ownerSale19,715,000$40.96$808M42,227,032Mar 4Form 4
Mar 4, 2026KKR & Co. Inc.10% ownerSale19,715,000$40.96$808M42,227,032Mar 4Form 4
Oct 22, 2025Lisa A NalleySee RemarksSale20,000$28.78$576K131,150Oct 22Form 4
Oct 22, 2025Jon B RousseauSee RemarksSale235,000$28.78$6.8M1,131,930Oct 22Form 4
Oct 22, 2025KKR Americas XII Ltd10% ownerSale14,745,000$28.78$424M62,351,337Oct 22Form 4
Oct 22, 2025Henry R Kravis10% ownerSale14,745,000$28.78$424M62,351,337Oct 22Form 4
🔒 10 more trades. Create a free account or sign in to see them all.

BTSG insider trading FAQ

Are BTSG insiders buying or selling?

Insiders are only selling over the last 12 months. 0 insiders bought $0 of BTSG on the open market in 0 trades, and 8 sold $3.4B in 11 trades.

When did an BTSG insider last buy shares?

There has been no open market insider purchase of BTSG in the last two years.

When did an BTSG insider last sell shares?

Scott A. Greenwell (President, PharMerica) sold 15,099 shares for $874K on Sep 14, 2026, under a pre-arranged trading plan.

What is a Form 4?

Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.

Why do insider sales matter less than buys?

Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.

From SEC Form 4 filings · Not investment advice